Titel

Merkliste
1 Ergebnisse

Baseline characteristics as predictors for the chance of no..:

Kristine Kaalund-Brok (11592699) ; Tine Bodil Houmann (11592702) ; Marie Bang Hebsgaard (11592705)...
https://figshare.com/articles/dataset/Baseline_characteristics_as_predictors_for_the_chance_of_normalisation_or_borderline_normalisation_of_the_clinician_rated_ADHD_core_symptoms_score_i_n_i_207_/16849491. , 2021

Link: https://doi.org/10.1371/journal.pone.0253727.t004

RT Journal
T1 <Title>Baseline characteristics as predictors for the chance of normalisation or borderline normalisation of the clinician rated ADHD core symptoms score ( n = 207)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16849491&Exemplar=1&LAN=DE
				
A1 Kristine Kaalund-Brok (11592699)
A1 Tine Bodil Houmann (11592702)
A1 Marie Bang Hebsgaard (11592705)
A1 Maj-Britt Glenn Lauritsen (11592708)
A1 Louise Hyldborg Lundstrøm (11592711)
A1 Helene Grønning (11592714)
A1 Lise Darling (11592717)
A1 Susanna Reinert-Petersen (11592720)
A1 Morten Aagaard Petersen (9635736)
A1 Jens Richardt Møllegaard Jepsen (11592723)
A1 Anne Katrine Pagsberg (10775600)
A1 Kerstin Jessica Plessen (3623210)
A1 Henrik Berg Rasmussen (11592726)
A1 Pia Jeppesen (661078)
YR 2021
K1 Medicine
K1 Neuroscience
K1 Pharmacology
K1 Biotechnology
K1 Science Policy
K1 Mental Health
K1 representative clinical sample
K1 representative clinical populations
K1 rating scale scores
K1 mental health services
K1 ecologically valid studies
K1 selection biases due
K1 children responded favourably
K1 div >< p
K1 treatment period questions
K1 describe treatment responses
K1 adhd )
K1 however
K1 0 %) children
K1 first 12 weeks
K1 2 %) children
K1 adhd </ p
K1 borderline normalisation (<
K1 first treatment
K1 n </
K1 discontinuation due
K1 borderline normalisation
K1 0 mg
K1 item adhd
K1 ars (<
K1 weight loss
K1 weekly assessments
K1 week 12
K1 reported efficacy
K1 registration number
K1 randomized placebo
K1 multiple domains
K1 mean end
K1 mean age
K1 investigated effectiveness
K1 harmful effects
K1 global impairment
K1 end 187
K1 controlled trials
K1 consecutively included
K1 capital region
K1 appetite reduction
K1 adverse reactions
K1 6 years
K1 12 )
JF https://figshare.com/articles/dataset/Baseline_characteristics_as_predictors_for_the_chance_of_normalisation_or_borderline_normalisation_of_the_clinician_rated_ADHD_core_symptoms_score_i_n_i_207_/16849491
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0253727.t004
DO https://doi.org/10.1371/journal.pone.0253727.t004
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)